Hamood Samuel A 4

What Happened
Samuel A. Hamood, a director of Definitive Healthcare Corp. (DH), was granted 189,190 restricted stock units (RSUs) on June 4, 2026. The Form 4 reports the acquisition at $0.00 per unit (award code A). These RSUs are a contingent right to receive Class A common shares in the future rather than immediate open‑market purchases.

Key Details

• Transaction date: June 4, 2026; Form 4 filed: June 9, 2026.
• Reported consideration: $0.00 per RSU (award), 189,190 RSUs granted.
• Vesting: RSUs vest on the earlier of June 4, 2027 or the company’s next annual meeting, subject to Hamood’s continued service. (Footnote: each RSU converts to one share upon vesting.)
• Shares owned following the reported transaction: not specified in the filing.
• Filing timeliness: filed five days after the grant and after the typical two-business‑day Form 4 deadline, i.e., appears to be filed late.

Context
RSU grants are a common form of director compensation and represent future, contingent stock delivery rather than an immediate purchase or sale. They do not necessarily signal the insider’s short‑term trading view of the company; purchases tend to be more directly indicative of bullish sentiment.